盈康生命(300143.SZ):全資子公司擬向中國青年創業就業基金會捐贈一套“頭部多源伽瑪射束立體定向放射治療系統
格隆匯1月11日丨盈康生命(300143.SZ)公佈,為支持少數民族地區公共衞生事業發展,推動當地醫療衞生服務水平提升,推進青年醫護人才隊伍建設,結合共青團援藏工作安排,公司全資子公司瑪西普醫學科技發展(深圳)有限公司(以下簡稱“瑪西普”)擬向中國青年創業就業基金會捐贈一套瑪西普品牌的“頭部多源伽瑪射束立體定向放射治療系統(型號:SRRS+)”(含一台治療設備和一套鈷放射源)以及為期三年的維護、材料更換等服務,定向用於資助西藏自治區林芝市有關醫療機構建設“盈康一生青年基層公共衞生教研實踐基地”,通過提升軟硬件條件,培育青年醫護人才,推動林芝市醫療衞生公益事業發展。
2022年1月11日,瑪西普與中國青年創業就業基金會、中國共產主義青年團西藏自治區委員會、林芝市人民政府就上述捐贈事項簽署了《捐贈合作協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.